• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周动脉疾病患者下肢动脉日间手术式血管内介入治疗的安全性及操作成功率:一项系统评价与荟萃分析

Safety and procedural success of daycase-based endovascular procedures in lower extremity arteries of patients with peripheral artery disease: a systematic review and meta-analysis.

作者信息

Hanna Lydia, Rodway Alexander D, Garcha Puneet, Maynard Luci, Sivayogi Janane, Schlager Oliver, Madaric Juraj, Boc Vinko, Busch Lucas, Whyte Martin B, Skene Simon S, Harris Jenny, Heiss Christian

机构信息

Department of Surgery and Cancer, Imperial College London, London, UK.

Vascular Medicine Department, Surrey and Sussex Healthcare NHS Trust, Redhill, UK.

出版信息

EClinicalMedicine. 2024 Sep 5;75:102788. doi: 10.1016/j.eclinm.2024.102788. eCollection 2024 Sep.

DOI:10.1016/j.eclinm.2024.102788
PMID:39290906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11406065/
Abstract

BACKGROUND

Timely and economic provision of revascularisation procedures is a major healthcare need. We aimed to examine the safety and efficacy of daycase-based lower extremity endovascular revascularisation procedures in patients with peripheral artery disease.

METHODS

In this systematic review and meta-analysis, we searched MEDLINE and Embase for studies from Jan 01, 2000 through Apr 01, 2024 reporting complications of lower limb endovascular revascularisation procedures with same-day discharge. Eligibility-criteria, complications, and patient characteristics were extracted, methodological quality assessed (adapted Newcastle-Ottawa Scale), and meta-analyses of complications and technical success performed to provide pooled estimates. This study is registered with PROSPERO, CRD42022316466.

FINDINGS

Thirty observational studies (17 retrospective, 13 prospective) and 1 RCT reported 2427 minor and 653 major complications after 99,600 daycase procedures (93,344 patients). Eighteen studies reported daycase eligibility-criteria including 'responsible adult companion' (78%), 'proximity to hospital', and 'telephone availability' and excluding unstable and severe co-morbidities, offset coagulation, and severe chronic kidney disease. Pooled incidences of minor (4.7% [95% CI 3.8-5.6%],  = 96%) and major (0.64% [95% CI 0.48-0.79%],  = 46%) complications were low and technical success high (93% [95% CI 91-96%],  = 97%). Most complications were related to the puncture site. Pooled conversion-to-hospitalisation rates and re-admission after discharge were 1.6% (95% CI 1.1-2.2%,  = 82%) and 0.11% (95% CI 0.095-0.23%,  = 97%), respectively. Meta-regression identified that minor complications decreased since 2000. Male sex and coronary artery disease were associated with more frequent, and higher age and closure device use with less minor complications. Diabetes mellitus and chronic kidney disease were associated with less major complications. Six studies reported complication rates both in daycases and inpatients and there was no significant difference (-0.8% [95% CI -1.9 to 0.3%]).

INTERPRETATION

After careful evaluation of eligibility, lower limb angioplasty can be performed safely with high technical success in a daycase setting. Most complications arise from the puncture site and not the procedure itself highlighting the importance of optimal access site management. The heterogeneity between studies warrants standardised monitoring of complications and outcomes.

FUNDING

European Partnership on Metrology, co-financed from European Union's Horizon Europe Research and Innovation Programme and UK Research and Innovation, and Medical Research Council.

摘要

背景

及时且经济地提供血管重建手术是一项重大的医疗需求。我们旨在研究基于日间手术的下肢血管腔内血管重建手术在周围动脉疾病患者中的安全性和有效性。

方法

在这项系统评价和荟萃分析中,我们检索了MEDLINE和Embase数据库,以查找2000年1月1日至2024年4月1日期间报告同日出院的下肢血管腔内血管重建手术并发症的研究。提取纳入标准、并发症和患者特征,评估方法学质量(采用改良的纽卡斯尔-渥太华量表),并对并发症和技术成功率进行荟萃分析以提供合并估计值。本研究已在PROSPERO注册,注册号为CRD42022316466。

结果

30项观察性研究(17项回顾性研究,13项前瞻性研究)和1项随机对照试验报告了99,600例日间手术(93,344例患者)后发生的2427例轻微并发症和653例严重并发症。18项研究报告了日间手术的纳入标准,包括“有责任的成年陪同人员”(78%)、“距离医院较近”和“可接通电话”,并排除不稳定和严重的合并症、凝血功能异常以及严重的慢性肾脏病。轻微并发症(4.7% [95%置信区间3.8 - 5.6%],I² = 96%)和严重并发症(0.64% [95%置信区间0.48 - 0.79%],I² = 46%)的合并发生率较低,技术成功率较高(93% [95%置信区间91 - 96%],I² = 97%)。大多数并发症与穿刺部位有关。合并的转为住院率和出院后再入院率分别为1.6%(95%置信区间1.1 - 2.2%,I² = 82%)和0.11%(95%置信区间0.095 - 0.23%,I² = 97%)。荟萃回归分析表明,自2000年以来轻微并发症有所减少。男性和冠状动脉疾病与更频繁的轻微并发症相关,而年龄较大和使用闭合装置与较少的轻微并发症相关。糖尿病和慢性肾脏病与较少的严重并发症相关。6项研究报告了日间手术和住院患者的并发症发生率,两者无显著差异(-0.8% [95%置信区间 -1.9至0.3%])。

解读

在仔细评估纳入标准后,下肢血管成形术可在日间手术环境中安全地进行,技术成功率较高。大多数并发症源于穿刺部位而非手术本身,这突出了优化穿刺部位管理的重要性。研究之间的异质性需要对并发症和结果进行标准化监测。

资助

欧洲计量伙伴关系,由欧盟“地平线欧洲”研究与创新计划、英国研究与创新以及医学研究理事会共同资助。

相似文献

1
Safety and procedural success of daycase-based endovascular procedures in lower extremity arteries of patients with peripheral artery disease: a systematic review and meta-analysis.外周动脉疾病患者下肢动脉日间手术式血管内介入治疗的安全性及操作成功率:一项系统评价与荟萃分析
EClinicalMedicine. 2024 Sep 5;75:102788. doi: 10.1016/j.eclinm.2024.102788. eCollection 2024 Sep.
2
Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.下肢外周动脉疾病的支架置入术:一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(18):1-88. Epub 2010 Sep 1.
3
Prognostic and predictive value of ultrasound-based estimated ankle brachial pressure index at early follow-up after endovascular revascularization of chronic limb-threatening ischaemia: a prospective, single-centre, service evaluation.基于超声的估计踝肱压力指数在慢性肢体威胁性缺血血管腔内血运重建术后早期随访中的预后和预测价值:一项前瞻性、单中心、服务评估研究
EClinicalMedicine. 2024 Jan 5;68:102410. doi: 10.1016/j.eclinm.2023.102410. eCollection 2024 Feb.
4
Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.血管成形术与支架置入术治疗慢性肢体威胁性缺血的腘下动脉病变
Cochrane Database Syst Rev. 2018 Dec 8;12(12):CD009195. doi: 10.1002/14651858.CD009195.pub2.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Duplex ultrasound for surveillance of lower limb revascularisation.下肢血运重建后监测的双功能超声检查。
Cochrane Database Syst Rev. 2023 Jul 20;7(7):CD013852. doi: 10.1002/14651858.CD013852.pub2.
7
8
Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis.静脉曲张的血管内射频消融术:基于证据的分析
Ont Health Technol Assess Ser. 2011;11(1):1-93. Epub 2011 Feb 1.
9
A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial.对于需要进行 below-the-knee(小腿)、伴或不伴额外更近端 below-inguinal(腹股沟下)血运重建以恢复肢体灌注的慢性肢体威胁性缺血患者,静脉旁路优先与最佳血管内治疗优先再血管化策略的比较(BASIL-2):一项开放标签、随机、多中心、3 期试验。
Lancet. 2023 May 27;401(10390):1798-1809. doi: 10.1016/S0140-6736(23)00462-2. Epub 2023 Apr 25.
10
Effectiveness of revascularisation for the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review.糖尿病合并外周动脉疾病患者足部溃疡血运重建的疗效:系统评价。
Diabetes Metab Res Rev. 2024 Mar;40(3):e3700. doi: 10.1002/dmrr.3700. Epub 2023 Aug 4.

引用本文的文献

1
Prognostic value of [F]FAZA PET/MR imaging pre and post revascularization in chronic limb-threatening ischemia: a prospective pilot study on tissue microcirculation.[F]FAZA PET/MR成像在慢性肢体威胁性缺血血管重建术前和术后的预后价值:一项关于组织微循环的前瞻性初步研究。
Eur J Nucl Med Mol Imaging. 2025 Aug 15. doi: 10.1007/s00259-025-07514-6.

本文引用的文献

1
Prognostic and predictive value of ultrasound-based estimated ankle brachial pressure index at early follow-up after endovascular revascularization of chronic limb-threatening ischaemia: a prospective, single-centre, service evaluation.基于超声的估计踝肱压力指数在慢性肢体威胁性缺血血管腔内血运重建术后早期随访中的预后和预测价值:一项前瞻性、单中心、服务评估研究
EClinicalMedicine. 2024 Jan 5;68:102410. doi: 10.1016/j.eclinm.2023.102410. eCollection 2024 Feb.
2
Endovascular interventions in outpatient care.门诊的血管内介入治疗。
Vasa. 2023 May;52(3):141-146. doi: 10.1024/0301-1526/a001067. Epub 2023 Mar 20.
3
Variations in Practice Patterns for Peripheral Vascular Interventions Across Clinical Settings.
不同临床环境下外周血管介入治疗实践模式的差异
Ann Vasc Surg. 2023 May;92:24-32. doi: 10.1016/j.avsg.2023.01.010. Epub 2023 Jan 13.
4
Editor's Choice - Prevalence of Peripheral Arterial Disease, Abdominal Aortic Aneurysm, and Risk Factors in the Hamburg City Health Study: A Cross Sectional Analysis.编辑推荐——汉堡市健康研究中周围动脉疾病、腹主动脉瘤的患病率及危险因素:一项横断面分析
Eur J Vasc Endovasc Surg. 2023 Apr;65(4):590-598. doi: 10.1016/j.ejvs.2023.01.002. Epub 2023 Jan 9.
5
Safety of short 3-hour recovery and same-day discharge following lower-limb angioplasty in outpatients with intermittent claudication and critical limb ischaemia.下肢血管成形术治疗间歇性跛行和严重肢体缺血患者的 3 小时短恢复和当天出院的安全性。
Clin Radiol. 2023 Mar;78(3):e182-e189. doi: 10.1016/j.crad.2022.10.009. Epub 2022 Nov 30.
6
Femoral or Radial Approach in Treatment of Coronary Chronic Total Occlusion: A Randomized Clinical Trial.股动脉或桡动脉入路治疗冠状动脉慢性完全闭塞:一项随机临床试验。
JACC Cardiovasc Interv. 2022 Apr 25;15(8):823-830. doi: 10.1016/j.jcin.2022.02.012.
7
Management of chronic peripheral artery disease patients with indication for endovascular revascularization.慢性外周动脉疾病患者血管内血运重建适应证的管理。
Vasa. 2022 May;51(3):121-137. doi: 10.1024/0301-1526/a000998. Epub 2022 Apr 14.
8
Procedural and 3-Year Outcomes of Peripheral Vascular Interventions Performed in Office-Based Labs: LIBERTY 360 Sub-Analysis.在基于办公室的实验室进行的外周血管介入治疗的程序和 3 年结果:LIBERTY 360 子分析。
J Invasive Cardiol. 2021 May;33(5):E365-E377. doi: 10.25270/jic/20.00594.
9
Lower extremity arterial interventions in England.英格兰的下肢动脉介入治疗。
Ann R Coll Surg Engl. 2021 May;103(5):360-366. doi: 10.1308/rcsann.2020.7090. Epub 2021 Apr 14.
10
Day case angioplasty in a secondary care setting - initial experience.二级医疗机构行日间经皮冠状动脉介入治疗-初步经验。
Vasa. 2021 Apr;50(3):202-208. doi: 10.1024/0301-1526/a000942. Epub 2021 Feb 18.